Interventions for treating post‐extraction bleeding

SK Nagraj, E Prashanti, H Aggarwal… - Cochrane Database …, 2018 - cochranelibrary.com
Background Post‐extraction bleeding (PEB) is a recognised, frequently encountered
complication in dental practice, which is defined as bleeding that continues beyond 8 to 12 …

Is alteration in single drug anticoagulant/antiplatelet regimen necessary in patients who need minor oral surgery? A systematic review with meta-analysis

TBB Calcia, HJR Oballe, AM de Oliveira Silva… - Clinical Oral …, 2021 - Springer
Objective This study aimed to systematically review literature about the effect of alteration of
the pharmacological regimen in adult patients using anticoagulants or antiplatelets who …

Hemostatic agents for the management of bleeding risk associated with oral anticoagulant therapy following tooth extraction: a systematic review

M Nisi, E Carli, S Gennai, F Gulia, R Izzetti - Applied Sciences, 2022 - mdpi.com
The occurrence of bleeding following dental extraction is a relatively common complication.
A history of therapy with oral anticoagulants represents a major favoring factor, both in …

Bleeding control measures during oral and maxillofacial surgical procedures: A systematic review

AR Akolkar, DG Kulkarni, KD Gangwani… - Journal of Dental …, 2017 - journals.lww.com
Surgical bleeding can be associated with an increased risk of morbidity and mortality across
all surgical areas. Thus, to avoid complications related to excessive bleeding, numerous …

Qualitative/chemical analyses of Ankaferd hemostat and its antioxidant content in synthetic gastric fluids

A Koluman, N Akar, UY Malkan… - BioMed research …, 2016 - Wiley Online Library
Introduction. Ankaferd hemostat (ABS) is the first topical haemostatic agent involving the red
blood cell‐fibrinogen interactions. The antihemorrhagic efficacy of ABS has been tested in …

[HTML][HTML] Functional and structural neurodegenerative activities of Ankaferd BloodStopper in a mouse sciatic nerve model

R Üstün, EK Oğuz, A Şeker… - Experimental …, 2024 - build.spandidos-publications.com
Traumatic and postoperative hemorrhages are life‑threatening complications. Ankaferd
BloodStopper (ABS) is a potent topical hemostatic agent to stop bleeding. However, ABS is …

Ankaferd hemostat: from molecules to medicine

R Ciftciler, IC Haznedaroğlu - Turkish Journal of Medical …, 2020 - journals.tubitak.gov.tr
Abstract Ankaferd hemostat (ABS; Ankaferd Blood Stopper®, İstanbul, Turkey) is a
hemostatic agent having an impact on red blood cell-fibrinogen interactions. The hemostatic …

A comparative evaluation of the effectiveness of chitosan-based dressing and conventional method of hemostasis in patients on oral antithrombotic therapy without …

S Seethamsetty, G Sarepally, A Sanober… - Journal of Pharmacy …, 2019 - journals.lww.com
Aims and Objectives: To assess the effectiveness of chitosan-based dressing after extraction
in individuals on antithrombotics, without modification of their treatment schedule. Materials …

Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper

C Simsek, S Selek, M Koca… - SAGE Open …, 2017 - journals.sagepub.com
Ankaferd blood stopper is a standardized mixture of the plants Thymus vulgaris, Glycyrrhiza
glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica and has been used as a topical …

Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)

R Ciftciler, AE Ciftciler, UY Malkan… - SAGE Open …, 2020 - journals.sagepub.com
Ankaferd hemostat (Ankaferd blood stopper [ABS], Istanbul, Turkey) is a hemostatic agent
affecting red blood cell-fibrinogen interactions. ABS has been traditionally used in Anatolia …